Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
MP Wattjes, O Ciccarelli, DS Reich, B Banwell… - The Lancet …, 2021 - thelancet.com
Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image
interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some …
interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some …
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
Diagnosis of multiple sclerosis: progress and challenges
The diagnosis of multiple sclerosis is based on neurological symptoms and signs, alongside
evidence of dissemination of CNS lesions in space and time. MRI is often sufficient to …
evidence of dissemination of CNS lesions in space and time. MRI is often sufficient to …
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
S Ramanathan, S Mohammad, E Tantsis… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective We characterised the clinical course, treatment and outcomes in 59 patients with
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination …
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination …
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment …
S Jarius, K Ruprecht, I Kleiter, N Borisow… - Journal of …, 2016 - Springer
Background A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has
been shown to be seropositive for myelin oligodendrocyte glycoprotein antibodies (MOG …
been shown to be seropositive for myelin oligodendrocyte glycoprotein antibodies (MOG …
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune
neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein …
neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein …